Volume 6, Number 5—October 2000
Research
Atypical Chryseobacterium meningosepticum and Meningitis and Sepsis in Newborns and the Immunocompromised, Taiwan
Figure 2

Figure 2. Random amplified polymorphic DNA fingerprinting (RAPD) types generated by arbitrarily primed PCR. Lanes 5-8 show results for the four index strains of the atypical Chryseobacterium meningosepticum, 96, 97-1, 97-2, and 97-3, respectively; lanes 1-4, four clinical isolates of C. meningosepticum from Canada; lanes 9-10, two clinical isolates of B. cepacia; lane 11, P. aeruginosa strain P1; and lane 12, clinical isolate of K. pneumoniae. Lane M shows the 1-kb DNA ladder.
Page created: December 17, 2010
Page updated: December 17, 2010
Page reviewed: December 17, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.